DRD NYSE Week ended 31 Jul 2026

Weekly Investor Report

DRDGOLD Limited ADR · Basic Materials · Gold

Open interactive chart View report data
Latest close 20.42 USD
-2.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -28.1% below the Trend Line and sits at 25.2% of its 52-week range. The latest completed week returned -2.5%, after a -6.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 42/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 17d.

Setup score 23 out of 100
Latest Close 20.42 USD 31 Jul 2026
1W Return -2.5% latest completed week
4W Return -6.8% short-term follow-through
12W Return -32.5% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.5% Latest completed week; four-week move -6.8%. Indicator stack 37/26 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 42/100 conviction; expected move 17.2%. News sentiment 58/100 36 relevant articles in the latest sentiment read. Event risk 17d Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -28.1% below the Trend Line and sits at 25.2% of its 52-week range. The latest completed week returned -2.5%, after a -6.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0412-week average 0.20

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.8% over four weeks, -32.5% over 12 weeks, and 50.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.5%
4W-6.8%
12W-32.5%
26W-35.2%
52W50.3%
Active trend streak0 weeks
Active weeks in one year35
Trend breadth67.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.27Latest activity-pressure read.
Pressure change-15.3%Four-week change in activity pressure.
Leadership-30.95Latest relative-leadership reading.
RS change-24.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value39/100Relative valuation strength. Underlying universe rank 62; rank 1 is best.
Quality38/100Profitability and accounting quality. Underlying universe rank 63; rank 1 is best.
Momentum39/100Medium-term price momentum. Underlying universe rank 62; rank 1 is best.
Growth39/100Revenue and earnings growth. Underlying universe rank 62; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
40.3%
Gross profit retained from each unit of revenue.
Operating margin
39.3%
Operating profit retained from revenue.
Free-cash-flow margin
79.9%
Free cash flow generated from revenue.
Return on invested capital
52.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
70.5%
Latest one-year revenue growth.
EPS growth
183.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
75.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.5%
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

DRD shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.19, expected move of 17.2%, and Sharemaestro trend signal inactive.

Conviction42/100
Expected move17.2%
Put/call volume0.19
Pressure78
Speculation3
Volatility90
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment58/100

Weighted news tone is neutral across 36 relevant articles.

16 positive · 18 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings17dNext report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
Options expected move17.2%Nearest-chain priced movement where available.
52-week drawdown-47.6%Distance below the 52-week high.
13-week volatility7.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+12.9%Week of 8 May.
Worst week-15.3%Week of 6 Mar.
Latest week-2.5%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses4
Sharp losses9
Recent vol7.1%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.04; No reversal markers Factors34/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 61 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options43/100

DRD shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.19, expected move of 17.2%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 17.2% Sentiment58/100

Weighted news tone is neutral across 36 relevant articles.

DRDGOLD Ltd (DRD) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings17d

Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.42 USD-2.5%28.39 USD15.55 USD-1.27-30.951.4MOff
24 Jul 202620.94 USD5.2%28.71 USD15.48 USD-1.23-28.241.7MOff
17 Jul 202619.90 USD-5.7%29.11 USD15.41 USD-1.11-31.991.6MOff
10 Jul 202621.10 USD-3.7%29.48 USD15.35 USD-1.07-28.822.0MOff
3 Jul 202621.90 USD2.5%29.81 USD15.28 USD-1.10-24.881.4MOff
26 Jun 202621.36 USD-12.4%30.04 USD15.20 USD-1.14-24.872.0MOff
19 Jun 202624.37 USD3.8%30.33 USD15.13 USD-1.29-15.971.4MOff
12 Jun 202623.47 USD-0.8%30.39 USD15.03 USD-1.37-17.931.6MOff
5 Jun 202623.66 USD-10.4%30.53 USD14.96 USD-1.40-16.471.6MOff
29 May 202626.40 USD1.7%30.60 USD14.87 USD-1.18-8.70999.0KOff
22 May 202625.95 USD-1.1%30.55 USD14.77 USD-1.21-8.511.1MOff
15 May 202626.25 USD-13.2%30.52 USD14.67 USD-1.19-6.261.0MOff
8 May 202630.23 USD12.9%30.59 USD14.57 USD-1.118.842.8MOff
1 May 202626.78 USD-8.1%30.53 USD14.45 USD-1.26-0.621.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.